Skip to content

MapLight Therapeutics, Inc. MPLT Prepaid & Other Current

Prepaid & Other Current at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.82B+17.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$27.5M-76.9%
AbbVie logo
AbbVieABBV
$150M-97.3%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$23.44M+28,339%
Alto Neuroscience logo
Alto NeuroscienceANRO
$5.36M+93.7%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$10.72M+47.7%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B+100%
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's prepaid & other current?
MapLight Therapeutics, Inc. (MPLT) reported prepaid & other current of $17.12M in Q1 2026.
How has MapLight Therapeutics, Inc. 's prepaid & other current changed year-over-year?
MapLight Therapeutics, Inc. 's prepaid & other current increased by 8767.9% year-over-year, from $193K to $17.12M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.